Difference between revisions of "User:Dileep D. Monie"

From OpenWetWare
Jump to: navigation, search
m
m
(One intermediate revision by the same user not shown)
Line 5: Line 5:
  
 
*Dileep Monie
 
*Dileep Monie
*Immunologist| Bioengineer | Entrepreneur  
+
*Immunologist | Bioengineer | Entrepreneur  
 
*Baltimore, MD, USA  
 
*Baltimore, MD, USA  
 
*[http://www.linkedin.com/in/dmonie Connect with me on LinkedIn]
 
*[http://www.linkedin.com/in/dmonie Connect with me on LinkedIn]
Line 37: Line 37:
 
*[http://openwetware.org/index.php?title=Special%3ALog&type=upload&user=Dileep+D.+Monie Upload log]
 
*[http://openwetware.org/index.php?title=Special%3ALog&type=upload&user=Dileep+D.+Monie Upload log]
  
<!--
 
 
==Publications==
 
==Publications==
 
<biblio>
 
<biblio>
Line 43: Line 42:
 
#Paper2 pmid=10441117
 
#Paper2 pmid=10441117
 
#Paper3 pmid=19298678
 
#Paper3 pmid=19298678
 +
#Paper4 pmid=21212284
 
#Book1 isbn=9780781764964
 
#Book1 isbn=9780781764964
 
// Contributed section on "Pulmonary Hypertension" (pp. 148-9)
 
// Contributed section on "Pulmonary Hypertension" (pp. 148-9)
 
</biblio>
 
</biblio>
-->
 

Revision as of 07:06, 23 January 2013

Contact Info

I learned about OpenWetWare from the 24C3 Endy lecture, and I've joined because I am interested in contributing to the BBF Technical Standards.

BBF Contributions

OWW Brain Dump

Publications

  1. Monday SR, Vath GM, Ferens WA, Deobald C, Rago JV, Gahr PJ, Monie DD, Iandolo JJ, Chapes SK, Davis WC, Ohlendorf DH, Schlievert PM, and Bohach GA. Unique superantigen activity of staphylococcal exfoliative toxins. J Immunol. 1999 Apr 15;162(8):4550-9. PubMed ID:10201994 | HubMed [Paper1]
  2. Vath GM, Earhart CA, Monie DD, Iandolo JJ, Schlievert PM, and Ohlendorf DH. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. Biochemistry. 1999 Aug 10;38(32):10239-46. DOI:10.1021/bi990721e | PubMed ID:10441117 | HubMed [Paper2]
  3. Kelly JR, Rubin AJ, Davis JH, Ajo-Franklin CM, Cumbers J, Czar MJ, de Mora K, Glieberman AL, Monie DD, and Endy D. Measuring the activity of BioBrick promoters using an in vivo reference standard. J Biol Eng. 2009 Mar 20;3:4. DOI:10.1186/1754-1611-3-4 | PubMed ID:19298678 | HubMed [Paper3]
  4. Oh U, McCormick MJ, Datta D, Turner RV, Bobb K, Monie DD, Sliskovic DR, Tanaka Y, Zhang J, Meshulam J, and Jacobson S. Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease. Blood. 2011 Mar 24;117(12):3363-9. DOI:10.1182/blood-2010-10-306571 | PubMed ID:21212284 | HubMed [Paper4]
  5. Rajnish Prasad, editor-in-chief; Scott Kahan, editor-in-chief; Pankaj Mohan, associate editor. In a page. Philadelphia: Lippincott Williams & Wilkins, 2007. ISBN:9780781764964 [Book1]
    Contributed section on "Pulmonary Hypertension" (pp. 148-9)
All Medline abstracts: PubMed | HubMed